Search Results - "Reef DK"

Ibrutinib plus venetoclax for patients with relapsed or refractory mantle cell lymphoma: an editorial on the phase 3 SYMPATICO trial.

Authors: Reef DK Grover N

Source: AME clinical trials review [AME Clin Trials Rev] 2026 Apr 25; Vol. 4. Date of Electronic Publication: 2025 Dec 17.

Publication Type: Journal Article

Journal Info: Publisher: AME Publishing Company Country of Publication: China NLM ID: 9918994995006676 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 3005-6152 (Electronic) Linking ISSN: 30056152 NLM ISO Abbreviation: AME Clin Trials Rev Subsets: PubMed not MEDLINE

Emerging Therapeutic Strategies in Cutaneous T-Cell Lymphoma: A Comprehensive Review of Clinical Trials.

Authors: Sacknovitz Y Ma R Bear CM et al.

Source: American journal of clinical dermatology [Am J Clin Dermatol] 2026 May; Vol. 27 (3), pp. 537-555. Date of Electronic Publication: 2026 Apr 01.

Publication Type: Journal Article; Review

Journal Info: Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 100895290 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-1888 (Electronic) Linking ISSN: 11750561 NLM ISO Abbreviation: Am J Clin Dermatol Subsets: MEDLINE

BIG TOPICS . . . BIG BOOKS; ILLUSTRATIONS ADD A VIVID DIMENSION TO LIFE OF PI

Authors: CHUCK ERION

Source: Record, The (Kitchener/Cambridge/Waterloo, ON). 12/01/2007.

ILLUSTRATIONS ADD A VIVID DIMENSION TO LIFE OF PI

Authors: CHUCK ERION

Source: Guelph Mercury (ON). 12/01/2007.

Central nervous system involvement in patients with Richter transformation of chronic lymphocytic leukemia (CLL): the Mayo Clinic experience.

Authors: Baccon D Atallah-Yunes SA Hampel PJ et al.

Source: Blood cancer journal [Blood Cancer J] 2026 Jan 07; Vol. 16 (1), pp. 7. Date of Electronic Publication: 2026 Jan 07.

Publication Type: Letter

Journal Info: Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE; In Process

Advances in Chimeric Antigen Receptor T-cell therapy for hematologic malignancies and autoimmune conditions: a review of the 2024 American Society of Hematology Annual Meeting.

Authors: Davis, Samuel Lutfi, Forat

Source: Frontiers in hematology 2025.

Journal Info: Publisher: Frontiers Media S.A. ISSN: 2813-3935